U.S. market Closed. Opens in 1 day 4 hours 54 minutes

NGM | NGM Biopharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue4.42M55.33M77.88M87.37M103.54M108.67M77.14M85.59M
Cost of Revenue2.22M5.98M7.90M163.97M129.25MN/AN/AN/A
Gross Profit2.20M49.35M69.98M-76.60M-25.71M108.67M77.14M85.59M
Operating Expenses148.74M221.58M198.58M191.20M152.88M112.98M94.57M93.95M
Selling, General & Admin36.73M40.52M36.87M27.23M23.63M17.27M14.83M11.85M
Research & Development112.01M181.07M161.71M163.97M129.25M95.71M79.74M82.11M
Other Operating Expenses-234.00K-132.00K-60.00K-593.00K-147.00K199.00K-152.00K133.00K
Operating Income-146.55M-166.25M-120.69M-103.83M-49.34M-4.31M-17.43M-8.36M
Other Expenses / Income4.17M3.58M360.00K1.35M6.54M3.82M2.21M1.94M
Before Tax Income-142.38M-162.67M-120.33M-102.49M-42.80M-493.00K-15.22M-6.42M
Income Tax ExpensesN/A-3.58M-6.51M-8.49M-14.30M3.82M-1.06M500.00K
Net Income-142.38M-159.09M-113.83M-93.99M-28.50M-493.00K-14.16M-6.92M
Interest ExpensesN/A3.71MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding82.50M79.95M77.09M68.48M50.30M64.99M53.65M53.65M
Diluted Shares Outstanding82.50M79.95M77.09M68.48M50.30M64.99M53.65M53.65M
EBITDA-144.33M-166.25M-120.69M-103.83M-49.34M2.91M-10.98M-4.83M
EBITDA Margin-3,267.51%-300.45%-154.97%-118.85%-47.65%2.68%-14.24%-5.64%
EBIT-142.38M-158.95M-120.33M-102.49M-42.80M3.33M-15.22M-6.42M
EBIT Margin-3,223.34%-287.27%-154.51%-117.30%-41.33%3.06%-19.73%-7.50%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙